CAS NO: | 667901-13-5 |
包装 | 价格(元) |
1mg | 电议 |
5mg | 电议 |
生物活性 | Zalutumumab is a high affinity, completely humanIgG1monoclonal antibody targetingEGFR. Zalutumumab binds to domain III of theEGFreceptor and acts by blocking the binding ofEGFand by sterically interfering with the active conformation of the receptor. Zalutumumab binds withIgGand its Fab fragment withEC50s of 7 and 19 nM, respectively. Zalutumumab can be used for the research ofcancer[1][2][3]. | ||||||||
体外研究 (In Vitro) | Zalutumumab (0-1 μM; 60 min) effectively blocks EGF-induced EGFR activation with an IC50value of 1.3 nM[2].Zalutumumab (0-1 μM; 96 h) affects proliferation of A431 cells[2].Zalutumumab (10 μg/mL; 24 h) induces a comparable percentage of specificlysis of A431 cells with mouse macrophages[3]. Cell Proliferation Assay[2]
| ||||||||
体内研究 (In Vivo) | Zalutumumab (5 mg/kg; i.p. 2 h after tumor induction) affects tumor growth in A431 xenograft models[3].Zalutumumab (0.5 and 5 mg/kg; i.p. once ) delays tumor growth when mice with tumor volumes of 80-100 mm3[3].
| ||||||||
Clinical Trial | |||||||||
CAS 号 | 667901-13-5 | ||||||||
储存方式 | Please store the product under the recommended conditions in the Certificate of Analysis. |